Cargando…
FoPA: identifying perturbed signaling pathways in clinical conditions using formal methods
BACKGROUND: Accurate identification of perturbed signaling pathways based on differentially expressed genes between sample groups is one of the key factors in the understanding of diseases and druggable targets. Most pathway analysis methods prioritize impacted signaling pathways by incorporating pa...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390332/ https://www.ncbi.nlm.nih.gov/pubmed/30808299 http://dx.doi.org/10.1186/s12859-019-2635-6 |
_version_ | 1783398121552740352 |
---|---|
author | Mansoori, Fatemeh Rahgozar, Maseud Kavousi, Kaveh |
author_facet | Mansoori, Fatemeh Rahgozar, Maseud Kavousi, Kaveh |
author_sort | Mansoori, Fatemeh |
collection | PubMed |
description | BACKGROUND: Accurate identification of perturbed signaling pathways based on differentially expressed genes between sample groups is one of the key factors in the understanding of diseases and druggable targets. Most pathway analysis methods prioritize impacted signaling pathways by incorporating pathway topology using simple graph-based models. Despite their relative success, these models are limited in describing all types of dependencies and interactions that exist in biological pathways. RESULTS: In this work, we propose a new approach based on the formal modeling of signaling pathways. Signaling pathways are formally modeled, and then model checking tools are applied to find the likelihood of perturbation for each pathway in a given condition. By adopting formal methods, various complex interactions among biological parts are modeled, which can contribute to reducing the false-positive rate of the proposed approach. We have developed a tool named Formal model checking based pathway analysis (FoPA) based on this approach. FoPA is compared with three well-known pathway analysis methods: PADOG, CePa, and SPIA on the benchmark of 36 GEO datasets from various diseases by applying the target pathway technique. This validation technique eliminates the need for possibly biased human assessments of results. In the cases that, there is no apriori knowledge of all relevant pathways, simulated false inputs (permuted class labels and decoy pathways) are chosen as a set of negative controls to test the false positive rate of the methods. Finally, to further evaluate the efficiency of FoPA, it is applied to a list of autism-related genes. CONCLUSIONS: The results obtained by the target pathway technique demonstrate that FoPA is able to prioritize target pathways as well as PADOG but better than CePa and SPIA. Also, the false-positive rate of finding significant pathways using FoPA is lower than other compared methods. Also, FoPA can detect more consistent relevant pathways than other methods. The results of FoPA on autism-related genes highlight the role of “Renin-angiotensin system” pathway. This pathway has been supposed to have a pivotal role in some neurodegenerative diseases, while little attention has been paid to its impact on autism development so far. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12859-019-2635-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6390332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63903322019-03-19 FoPA: identifying perturbed signaling pathways in clinical conditions using formal methods Mansoori, Fatemeh Rahgozar, Maseud Kavousi, Kaveh BMC Bioinformatics Research Article BACKGROUND: Accurate identification of perturbed signaling pathways based on differentially expressed genes between sample groups is one of the key factors in the understanding of diseases and druggable targets. Most pathway analysis methods prioritize impacted signaling pathways by incorporating pathway topology using simple graph-based models. Despite their relative success, these models are limited in describing all types of dependencies and interactions that exist in biological pathways. RESULTS: In this work, we propose a new approach based on the formal modeling of signaling pathways. Signaling pathways are formally modeled, and then model checking tools are applied to find the likelihood of perturbation for each pathway in a given condition. By adopting formal methods, various complex interactions among biological parts are modeled, which can contribute to reducing the false-positive rate of the proposed approach. We have developed a tool named Formal model checking based pathway analysis (FoPA) based on this approach. FoPA is compared with three well-known pathway analysis methods: PADOG, CePa, and SPIA on the benchmark of 36 GEO datasets from various diseases by applying the target pathway technique. This validation technique eliminates the need for possibly biased human assessments of results. In the cases that, there is no apriori knowledge of all relevant pathways, simulated false inputs (permuted class labels and decoy pathways) are chosen as a set of negative controls to test the false positive rate of the methods. Finally, to further evaluate the efficiency of FoPA, it is applied to a list of autism-related genes. CONCLUSIONS: The results obtained by the target pathway technique demonstrate that FoPA is able to prioritize target pathways as well as PADOG but better than CePa and SPIA. Also, the false-positive rate of finding significant pathways using FoPA is lower than other compared methods. Also, FoPA can detect more consistent relevant pathways than other methods. The results of FoPA on autism-related genes highlight the role of “Renin-angiotensin system” pathway. This pathway has been supposed to have a pivotal role in some neurodegenerative diseases, while little attention has been paid to its impact on autism development so far. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12859-019-2635-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-26 /pmc/articles/PMC6390332/ /pubmed/30808299 http://dx.doi.org/10.1186/s12859-019-2635-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Mansoori, Fatemeh Rahgozar, Maseud Kavousi, Kaveh FoPA: identifying perturbed signaling pathways in clinical conditions using formal methods |
title | FoPA: identifying perturbed signaling pathways in clinical conditions using formal methods |
title_full | FoPA: identifying perturbed signaling pathways in clinical conditions using formal methods |
title_fullStr | FoPA: identifying perturbed signaling pathways in clinical conditions using formal methods |
title_full_unstemmed | FoPA: identifying perturbed signaling pathways in clinical conditions using formal methods |
title_short | FoPA: identifying perturbed signaling pathways in clinical conditions using formal methods |
title_sort | fopa: identifying perturbed signaling pathways in clinical conditions using formal methods |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390332/ https://www.ncbi.nlm.nih.gov/pubmed/30808299 http://dx.doi.org/10.1186/s12859-019-2635-6 |
work_keys_str_mv | AT mansoorifatemeh fopaidentifyingperturbedsignalingpathwaysinclinicalconditionsusingformalmethods AT rahgozarmaseud fopaidentifyingperturbedsignalingpathwaysinclinicalconditionsusingformalmethods AT kavousikaveh fopaidentifyingperturbedsignalingpathwaysinclinicalconditionsusingformalmethods |